newsfilter
← Latest News
GlobeNewswire·

Tourmaline Bio to Present at the Guggenheim Securities SMID Cap Biotech Conference

NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ:TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients